Asset Details
Do you wish to reserve the book?
Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage
Do you wish to request the book?
Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage
2014
Overview
Kidney damage represents a frequent event in the course of hypertension, ranging from a benign to a malignant form of nephropathy depending on several factors, that is, individual susceptibility, degree of hypertension, type of etiology and underlying kidney disease. Multiple mechanisms are involved in determination of kidney glomerular, tubular and interstitial injuries in hypertension. The present review article discusses relevant contributory molecular mechanisms underpinning the promotion of hypertensive renal damage, such as the renin–angiotensin–aldosterone system (RAAS), oxidative stress, endothelial dysfunction, and genetic and epigenetic determinants. We highlighted major pathways involved in the progression of inflammation and fibrosis leading to glomerular sclerosis, tubular atrophy and interstitial fibrosis, thus providing a state of the art review of the pathogenetic background useful for a better understanding of current and future therapeutic strategies toward hypertensive nephropathy. An adequate control of high blood pressure, obtained through an appropriate therapeutic intervention, still represents the key strategy to achieve a satisfactory control of renal damage in hypertension. In this regard, we reviewed the impact of currently available antihypertensive pharmacological treatment on kidney damage, with particular regard to RAAS inhibitors. Notably, recent findings underscored the ability of the kidneys to regenerate and to repair tissue injuries through the differentiation of resident embryonic stem cells. Pharmacological modulation of the renal endogenous reparative process (that is, with angiotensin-converting enzyme inhibitors and AT1 angiotensin II receptor blockers), as well as future therapeutic strategies targeted to the renopoietic system, offers interesting perspectives for the management of hypertensive nephropathy.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ Angiotensin-converting enzyme inhibitors
/ Animals
/ Antihypertensive Agents - therapeutic use
/ Atrophy
/ Blood Pressure - drug effects
/ Endothelium, Vascular - metabolism
/ Endothelium, Vascular - physiopathology
/ Etiology
/ Fibrosis
/ Genetic Predisposition to Disease
/ Humans
/ Hypertension - complications
/ Hypertension - physiopathology
/ Inflammation Mediators - metabolism
/ Kidney Diseases - metabolism
/ Kidney Diseases - physiopathology
/ Kidney Diseases - prevention & control
/ Kidneys
/ Medicine
/ Renin
/ review
